24
2016.9
The U.S. Food and Drug Administration today approved Taltz (ixekizumab) to treat adults with moderate-to-severe plaque psoriasis. Psoriasis is a skin condition that causes patches of skin redness and f…
Insgesamt 3 Seite/ 3 Seiten
+86-13149347204
@Catochem
CATO72404463info@cato-chem.com
standards@cato-chem.com
Zurück zur Startseite
